Trials / Recruiting
RecruitingNCT07303140
Non-invasive Assessment of Liver Fibrosis in a French Cohort of Pediatric Patients With Type III Glycogen Storage Disease: Current State and Perspectives
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 1 Month – 21 Years
- Healthy volunteers
- —
Summary
Patients with type III glycogen storage disease (GSDIII) can develop liver fibrosis, which can be complicated by liver failure or even hepatocellular carcinoma. Since the beginning of the 21st century, non-invasive techniques for assessing fibrosis, such as liver elastography, have been developed. These techniques often make it possible to avoid liver biopsies during patient follow-up and have already been validated in the management of several diseases in adults. These techniques are also beginning to be recommended for monitoring certain chronic liver diseases in children.
Conditions
Timeline
- Start date
- 2024-10-18
- Primary completion
- 2026-02-01
- Completion
- 2026-02-01
- First posted
- 2025-12-24
- Last updated
- 2025-12-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07303140. Inclusion in this directory is not an endorsement.